Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good Morning Peeps..
Sell if you want .. if you are a flipper then this may be your best chance now to take your profits and run. But..
This is a classic example of what I talked about yesterday. The company is still the same company as it was yesterday and the day before. The financials are still just as sound as they were then. There was NO bad news released, this is just a panic sell off. Resist the temptation to sell, emotions have nothing to do with successful stock trading.
Good Morning Peeps..
Some people just never learn I guess.
I found this CBD article on one of the major news networks today.. its a quick read. It talks about how some businesses are overcoming their various issues with selling CBD products and such.
Suddenly, CBD is everywhere
The CBD gold rush has begun.
CBD, the chemical found in hemp and marijuana plants, is showing up in shampoos, lattes, body oils, gummy bears and dog treats. It's being sold in coffee shops and farmer's markets, mom-and-pops and high-end department stores and most recently, drugstore chain CVS.
"Literally overnight, you're seeing CBD all around you and in everything," said Troy Dayton, CEO of The Arcview Group, an Oakland, California-based cannabis investment and research firm. "This is a product that is going from relative obscurity to being on everyone's mind: producers, consumers and especially entrepreneurs."
The CBD floodgates opened after President Donald Trump signed the Farm Bill into law in December. Among other things, the bill legalized the production of hemp, which contains high levels of cannabidiol, or CBD. CBD is non-psychoactive, meaning it won't get you high. (THC, or tetrahydrocannabinol, is the chemical in cannabis that does that.) Instead, CBD is marketed for everything from helping to relieve pain and inflammation to reducing stress and anxiety.
He took the leap into cannabis. Now everyone is following
Yet, the Food & Drug Administration still hasn't decided how to regulate CBD products. In a recent interview with Brookings Institution, outgoing FDA commissioner Scott Gottlieb said it could take several years before the agency fully legalizes CBD for use in food products and dietary supplements.
So far, little clinical research has been conducted to prove CBD's effectiveness. Last year, the FDA approved the first drug containing CBD for the treatment of certain forms of epilepsy, but no other drugs have been approved since.
Dayton cautions that there's also a lack of standardization in terms of recommended doses and quality control.
"As exciting as this is, it gives rise to some challenges," he says. "Standardization and testing are important. Otherwise, it's hard to differentiate hype from reality in terms of determining the efficacy of CBD products."
A lack of access to banking remains another hurdle.
"We've talked to clients who are still struggling to find a bank willing to work with them and we've spoken with banks and credit unions who want to support the hemp industry, but still feel there is considerable risk attached to the CBD industry," says Evan Eneman, CEO of MGO\ELLO National Cannabis Alliance, a financial and tax advisory service for the cannabis industry. "Both sides want clear, actionable banking guidelines from the federal government."
Despite these roadblocks, the Arcview Group projects sales of CBD products will outpace legal marijuana sales in the United States in five years. Here are some of the entrepreneurs hoping to cash in.
'We want customers to trust our products'
"For us, 2018 is the year when so many of our big problems started to go away," says Chase Terwilliger, CEO of Denver-based Balanced Health Botanicals.
Before the Farm Bill passed, many banks and payment processing companies refused to work with his company.
"We had accounts at many large banks and they all shut us down," he says. "Now, banks and credit card processing companies are calling constantly to lend us money."
Founded as CBDistillery in 2015, the company initially sold pure, hemp-derived CBD extract in powders that could be added to food and beverages or mixed in with oils and lotions.
Sales have soared as the business has expanded its portfolio to include oils, tinctures, capsules and gummies. In 2016, the firm logged $200,000 in sales, he said. Last year, annual revenue was $41 million and Terwilliger projects sales will double to $80 million by the end of this year.
"We've now grown to 101 employees, our products are sold in all 50 states and I have 20 open positions in Denver to fill," he says.
Terwilliger says he's trying to navigate the CBD industry landscape responsibly. He says the company tests each product at three separate labs to make sure they meet standards, such as ensuring THC levels do not exceed 0.3%, (as mandated by federal law) and the products don't contain contaminants like heavy metals.
"We're doing this voluntarily because there is a lack of standardization in the CBD industry and we want consumers to trust our products," he says.
High-end retail embraces CBD
Soon after Katherine, Alison and Juliana Ragusa launched their Lab to Beauty line of CBD-infused face washes, masks and moisturizers, it was being stocked on the shelves at high-end retail chain Barneys New York.
The sisters, who started developing the line early last year, already had in-house expertise on creating and marketing beauty products through their family business, The Advantage Co., which manages a portfolio of beauty, fashion and jewelry brands and restaurants. They worked directly with hemp farmers to source the CBD and with Advantage Co.'s lab and scientists to formulate the products.
By summer, after they had tested the products with a third party lab, they sent samples to Barneys' beauty team.
"It was exciting for us to see how open they were to trying our samples on the spot," says Katherine Ragusa.
Jennifer Miles, Barneys' senior vice president, divisional merchandise manager, cosmetics, says the department store chain had been looking for a CBD skincare line. She says Barneys is trying to address customers' misconceptions around CBD "as it is becoming more mainstream and customers are learning about the benefits, and how to add these products to their wellness routine."
Barney's. Neiman Marcus. America's stores are taking the leap into cannabis products
The line of eight products is now sold in seven Barneys locations, including its stores in New York, Chicago and Beverly Hills and on Barneys.com.
"The response has been tremendous. Barneys sold out of some of the products online, but we have now replenished the supplies," says Katherine.
A market for mints, pets and beyond
College friends, Tim Moxey and Chris Abbott, launched BotanicaSeattle in 2012 with a line of cannabis-infused chocolates. Since then, they've added Mr. Moxey's CBD Mints, and a line of CBD products for pets called Austin & Kat that includes biscuits and oils they claim can provide pain relief and calm anxiety in dogs, cats and other animals.
Last year, the company logged about $7 million in sales and Moxey expects sales to hit $20 million at the end of this year.
But getting to this point has required winning over consumers and building trust.
"We've chatted with customers who purchased other products they found on the internet and felt they were duped because those products didn't contain the stated amount of CBD, or contained trace amounts of THC," says Moxey. "Pushing to build trust and transparency is difficult in this industry where there are so many dishonest companies entering the market every day."
He hopes the FDA will move quickly to establish quality control guidelines.
Moxey says the company has several new CBD products in the pipeline, including topical solutions and other pet products.
"As we educate people about our products and as research continues, our long-term goal is to make products that bring the cannabis plant into people's lives in a meaningful way," he says.
To Alaskawolf..
You might want to check your emails before you send them.. I dont think that one you sent was meant for me. I was replaying to a quoted statement.. not making it.
Good Morning Peeps..
I have been there too and sold during a panic. More than once. I have learned since then not to trade by emotion.
Look at the stock. If the numbers are good like they are here and the company is in good shape, especially if there is NO bad news then hold no matter what. Stocks have sell off periods but if there is no real obvious reason for it then hold. Its still the same great company that it was when you bought in.
During the short attack last year I did just that. I am glad I held even though I was pissed off, and had my finger on the button a few times but remembered my own advice.
This run up is similar to the last, only the company has a few more positive earning reports under its belt so its way possible that these gains are here to stay with more to come. We have all been saying our time will come, maybe this is it. Its as good a time as any.
Good Morning Peeps..
I like the price action lately.. but what I really like is the uptick in the MoneyFlow indicator that I keep an eye on. Its not as well known as the MACD or Stochastic indicators but its up. Has not been moving up like this in a LONG time, currently around +7.5 Million dollars and climbing. This is a very good sign. The last time this indicator was climbing like this was the run to $9 back in the day.
Good Morning Peeps..
Good Morning Peeps..
Nice move yesterday, and there is a positive money flow from buyers right now to boot.
According to one tool that I look at on a regular basis, the next resistant points are 5.14 and 5.26 .. I would love to see us smash through those two points this week.
NASDAQ is still a must in my eyes, and it will happen. Only no one knows when so we wait. Get us OFF the OTC please!!
The convergence points from the Pennant forming is just around the corner. If the pattern plays out like a classic pennant then this stock is about to jump. Only time will tell though, charting is not an exact science.
GLTA
Great find! Thanks!
Good Morning Peeps..
I don't have a chart to post this time but here are some obvious things from the charts..
Everything went to hell when the support line broke. The 10 DMA is below the 50 DMA and dropping, even if not by much. It needs to climb and get back on top of the 50 DMA to show some strength.
The Pennant pattern is still there, you can use the former line of support or create a new one. Either way the upper end and lower end are converging. This can be a sign of a pending break out.. and if it does the recent highs have only been like $5.50 so either look for that as resistance, or sell at that point if you flip shares.
Thats really all I have at this time. Lots of sideways consolidation going on right now, and will probably continue until something newsworthy comes along.
Good Morning Peeps..
If anyone is still tracking online orders, I just placed one..
Order number 442204
Good Morning Peeps..
As for all the facts that some naysayers are posting, well I agree. They are indeed facts. Some are just not all that relevant. Nashville is the capital of Tennessee (fact) but on the CVSI board who cares?
Some of the facts I have seen have a one in a million chance of becoming a reality, but the chance is still there so its still a fact. My point is weight this stuff out and decide what really is important.
For example : No NASDAQ uplisting. This is a popular fact being tossed around and yes its true. But for how much longer? The company is doing everything in its power to get this done. Here is another fact : CVSI has NOT been denied membership to NASDAQ either.
The entire uplisting process has been good for the company. Things have happened that probably would not have happened had they not applied for NASDAQ membership. Auditing the financials revealed a better way to do the financials, they have shown the need for a CFO, and Mona II is long gone. Who knows if these things would have happened or not without the uplist request? But the fact is once these issues have been addressed, CVSI will be better off.
Let the naysayers point out the flaws. This is not your every day OTC scam. The issues are being addressed and fixed and then the naysayers wont have anything to point out. Its not like the company is perfect, but it IS getting better.. and that my friends is a fact.
So in short, if I am understanding correctly.. the issue is NOT the numbers, they are fine. The issue is the internal accounting process. That may be an over simplification, but its the jist of the situation?
If so, that's an easy fix for management. Let them revamp the processes and give them time to test. It all works out in the wash.
I am no rocket scientist, but judging by the conversation I am guessing a certain someone is trying cast doubt over the recent audited financials?
Sorry, but I really don't see how there can be any doubt. I am no CPA but an Unqualified Opinion is good enough for me, and probably 99% of anyone else out there. The remaining 1% are probably just trouble makers that site examples that are remotely possible but the odds of being true, especially in this case, are probably astronomical.
Why would a company that is applying for membership to Nasdaq try to pull a fast one when they know that everything they do is being examined under a microscope?
Good Morning Peeps..
I saw this in a post from KentuckyHemp:
Things to Remember for Next Quarter:
If I am not mistaken the same thing has happened for the past two quarterly reports as well. The day after earnings was announced, there was a sell off right at opening. This is a classic "buy the rumor sell the news" scenario. If you are so inclined, you may want to have some money ready for the dip to buy more shares at a discounted price if it happens again. If it doesn't then you have some spare beer money handy, no loss.
The next thing to remember is that Vandy was right about one thing.. we did guess a little high on the revenues this time around. Maybe next time we might want to slow our roll a little and not be so optimistic. Its a great company, no doubt.. but its no Proctor & Gamble just yet.
I plan on referring back to both of these issues in the upcoming months.
Spin it any way you want, the financials speak for themselves. I dare anyone to show me any other company on the OTC that has better fundamentals than CVSI's. Please do, and I will invest in them as well.
Good Morning Peeps..
Its Day After. The numbers were good, increased revenue was to be expected, and they did. Another record setting quarter at that. Profits were there as well, although I am still wanting them to start increasing.. who doesn't! I don't claim to know how to run this business so I will leave that to the management team.
The numbers were not through the roof by any means, so I don't expect the stock to run through the roof. They were more normal, and that what I expect from the stock today.. normal trading. Its sad when a company sets a record for revenues and that becomes normal. Not a bad problem to have at all and I will take it every quarter from here on out.
Keep the revenues increasing and keep posting profits, and Wall Street will come knocking.
LOL.. thanks Genos.. not the issue. Hard to dial in to a conference call when I am already on my phone with someone else. Damn day jobs..